InicioSTAR • NSE
add
Strides Pharma Science Ltd
Cierre anterior
970,85 ₹
Intervalo diario
931,85 ₹ - 970,05 ₹
Intervalo anual
513,05 ₹ - 1025,00 ₹
Cap. bursátil
86,27 mil M INR
Volumen medio
305,52 mil
Relación precio-beneficio
21,70
Rentabilidad por dividendo
0,43 %
Bolsa de valores principal
NSE
En las noticias
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (INR) | sept 2025info | Cambio interanual |
|---|---|---|
Ingresos | 12,21 mil M | 1,64 % |
Gastos operativos | 5236,46 M | 1,11 % |
Ingresos netos | 1275,34 M | 36,79 % |
Margen de beneficio neto | 10,45 | 34,66 % |
Beneficios por acción | — | — |
EBITDA | 2311,88 M | -1,56 % |
Tipo impositivo efectivo | 14,10 % | — |
Balance general
Activos totales
Responsabilidades totales
| (INR) | sept 2025info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 2274,59 M | -7,91 % |
Activos totales | 65,21 mil M | 8,86 % |
Responsabilidades totales | 37,18 mil M | -1,50 % |
Patrimonio total | 28,03 mil M | — |
Acciones en circulación | 92,15 M | — |
Precio-valor contable | 3,25 | — |
Rentabilidad económica | — | — |
Retorno sobre capital | 9,98 % | — |
Flujo de caja
Variación neta del flujo de caja
| (INR) | sept 2025info | Cambio interanual |
|---|---|---|
Ingresos netos | 1275,34 M | 36,79 % |
Efectivo de operaciones | — | — |
Efectivo de inversión | — | — |
Efectivo de financiación | — | — |
Variación neta del flujo de caja | — | — |
Flujo de caja libre | — | — |
Información sobre la empresa
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Fundación
1990
Sitio web
Empleados
3.301
